NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
February 5, 2020
Altavant Sciences, headquartered in Cary, is balancing the development of two promising compounds to treat two rare respiratory diseases.
February 4, 2020
Morrisville-based Liquidia Technologies has filed a New Drug Application with the FDA for LIQ861, an inhaled dry powder using its micro-particle engineering technology to treat patients with pulmonary arterial hypertension.
February 4, 2020
Alcami Corp., a contract development and manufacturing organization (CDMO) headquartered in Durham and with major operations in Wilmington, has expanded its drug-making capacity by acquiring TriPharm Services.
February 3, 2020
Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner.
January 31, 2020
AskBio has launched a unique outreach program, called AskFirst, to communicate information and support during clinical trials to patients and their families.
January 30, 2020
Raleigh-based biotechnology company Arrevus has received an important FDA designation to support development of its drug to address the worsening symptoms of cystic fibrosis.
January 28, 2020
bluebird bio, a gene therapy company with operations in Durham, has launched for the first time its treatment for a severe inherited blood disorder, in Germany.
January 28, 2020
Raleigh ranks second on Numbeo’s Quality of Life Index for 2020 and Charlotte is #9 out of the 227 cities ranked around the world.
January 22, 2020
Scientists say treating allergies in people provides insight into ways to treat animals with similar problems.
January 22, 2020
Plant Response, a Spanish agricultural biologicals company with North American headquarters in Durham, has acquired Pathway BioLogic of Plant City, Fla
January 21, 2020
Global pharmaceutical giant Eli Lilly and Company will build its first North Carolina manufacturing facility in the Durham County portion of Research Triangle Park, investing $474 million and creating 462 new jobs.
January 17, 2020
Durham-based CoImmune, a cell therapy company acquired by two South Korean biotech firms last year, will continue to grow through a merger with another East Coast biotech firm.
January 16, 2020
Alexandria Launch Labs is offering a $100,000 prize that includes $75,000 in cash and a one-year membership at Alexandria Center for AgTech for one innovative startup.
January 14, 2020
The FDA has accepted the company’s Investigational New Drug (IND) application and also granted the therapy Orphan Drug Designation, a status that gives companies tax reductions and other incentives to develop treatments for rare diseases.
January 13, 2020
Burlington-based LabCorp has introduced a suite of cell and gene therapy development services from Covance, its drug development business, to help biopharmaceutical companies develop cell and gene therapies for cancer and other diseases.